본문 바로가기

Role of PTEN promoter methylation in tamoxifen-resistant breast cancer cells

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q1
저널
BREAST CANCER RESEARCH AND TREATMENT130(1) · pp.73 · 2011
피인용
Web of Science 71
JCR IF
JCR 2010 4.859
ISSN
0167-6806

저자

  1. Phuong, Nguyen Thi Thuy제1저자BK21 Project Team, College of Pharmacy, Chosun University, South Korea
  2. Kim, Sang KyumCollege of Pharmacy, Chungnam National University, South Korea
  3. Lim, Sung ChulDepartment of Pathology, College of Medicine, Chosun University, South Korea
  4. 김형식College of Pharmacy, Pusan National University, South Korea
  5. 김태형College of Pharmacy, Pusan National University, South Korea
  6. Lee, Kwang YeolCollege of Pharmacy, Chonnam National University, South Korea
  7. Ahn, Sang-GunDepartment of Pathology, College of Medicine, Chosun University, South Korea
  8. Yoon, Jung-HoonDepartment of Pathology, College of Medicine, Chosun University, South Korea
  9. Kang, Keon Wook교신저자BK21 Project Team, College of Pharmacy, Chosun University, South Korea

초록

Tamoxifen (TAM) resistance is a serious clinical problem in the treatment of breast cancer. Here, we found that S-adenosylmethionine (SAM) and DNA methyltransferase1 (DNMT1) expression are up-regulated in TAM-resistant breast cancer (TAMR-MCF-7) cells. We further focused on whether increased SAM with DNMT1 overexpression in TAMR-MCF-7 cells lead to aberrant methylation of the PTEN gene promoter and its therapeutic potential. Methylation-specific PCR analyses revealed that two sites within the PTEN promoters were methylated in TAMR-MCF-7 cells, which resulted in down-regulation of PTEN expression and increase in Akt phosphorylation. Both the loss of PTEN expression and the increased Akt phosphorylation in TAMR-MCF-7 cells were completely reversed by 5-aza-2'-deoxycytidine (5-Aza), a DNMT inhibitor. 5-Aza inhibited the basal cell proliferation rate of TAMR-MCF-7 cells and intraperitoneal injection of 5-Aza significantly suppressed TAMR-MCF-7 tumor growth in a xenograft study. Immunohistochemistry showed that PTEN expression in TAM-resistant human breast cancer tissues was lower than in TAM-responsive cases. These results suggest that methylation of the PTEN promoter related to both SAM increase and DNMT1 activation contributes to persistent Akt activation and are potential therapeutic targets for reversing TAM resistance in breast cancer.

키워드

Tamoxifen resistancePTENMethylationS-adenosylmethionineMETHIONINE ADENOSYLTRANSFERASE 2AADENOSYL-L-METHIONINES-ADENOSYLMETHIONINEDNA METHYLATIONGENE-EXPRESSIONCOLON-CANCERSIGNALING PATHWAYGASTRIC-CARCINOMALIVER-CANCERCYTOSINE-DNA

식별자

WoS UID
000295363200008